Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADD study: nucleos(t)ide analogue pretreatment before peg-interferon alfa-2b in HBeAg-positive chronic hepatitis B
2008-007446-54Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Dec 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Erasmus MC. Started Dec 2008; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2008-007446-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007446-54.